Humana
HUMANA INC
NYSE: HUM. Canonical company identity and public leadership record.
US
- Alpha ID
- alpha:company:c1aa5809-cafb-4c18-8613-236fb1c5da0e
- SEC CIK
- 0000049071
- Website
- www.humana.com Open
- Record version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 15, 2026
- Newest evidence
- May 3, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- James A. RechtinPresident and Chief Executive Officer, Director
- Chair
- Kurt J. Hilzinger
- Independent
- 8 / 99 directors published
- Published claims
- 525 distinct sources
- Evidence records
- 150 pinned
- Source conflicts
- 0None open
Built from 5 distinct sources and 15 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
DIRECTOR APPOINTED
Gordon Smith seat on Humana, effective 2024-01-01.
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| President, Medicare Advantage | Aaron C. Martin | Not captured | unknown | Source reportedE4 |
| Chief Financial Officer | Celeste M. Mellet | Not captured | unknown | Source reportedE5 |
| President, Enterprise Growth | David E. Dintenfass | Not captured | unknown | Source reportedE6 |
| President, Insurance | George Renaudin II | Not captured | unknown | Source reportedE7 |
| President and Chief Executive Officer, Director | James A. Rechtin | Not captured | unknown | Source reportedE8 |
| Chief Information Officer | Japan A. Mehta | Not captured | unknown | Source reportedE9 |
| Senior Vice President, Chief Accounting Officer and Controller | John-Paul W. Felter | Not captured | unknown | Source reportedE10 |
| Chief Legal Officer | Joseph C. Ventura | Not captured | unknown | Source reportedE11 |
| Chief Human Resources Officer | Michelle A. O'Hara | Not captured | unknown | Source reportedE12 |
| President, CenterWell | Sandra Horning, M.D. | Not captured | unknown | Source reportedE13 |
Board of directors
Evidence9 directors published. 8 of 9 with a published determination are independent.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| David T. Feinberg | Independent | 2022 | Clinical QualityNominating, Governance & SustainabilityNominating, Governance & Sustainability; Clinical Quality | Source reportedE3 |
| Frank A. D'Amelio | Independent | 2003 | AuditAudit; Nominating, Governance & SustainabilityNominating, Governance & Sustainability | Source reportedE3 |
| Gordon Smith | Independent | 2024 | Organization & CompensationOrganization & Compensation; TechnologyTechnology | Source reportedE3 |
| James A. Rechtin | Not independent | 2024 | None published | Source reportedE3 |
| Jorge S. Mesquita | Independent | 2021 | Clinical QualityInvestmentInvestment; Clinical Quality | Source reportedE3 |
| Karen W. Katz | Independent | 2019 | Nominating, Governance & SustainabilityOrganization & CompensationOrganization & Compensation; Nominating, Governance & Sustainability | Source reportedE3 |
| Kurt J. Hilzinger | IndependentChair | 2003 | Investment | Source reportedE3 |
| Marcy S. Klevorn | Independent | 2021 | AuditAudit; TechnologyTechnology | Source reportedE3 |
| Raquel C. Bono M.D | Independent | 2020 | None published | Source reportedE3 |
| John W. Garratt | Independence not published | Not published | AuditInvestment | Source reportedE14 |
| Wayne A.I. Frederick M.D | Independent | Not published | Organization & CompensationOrganization & Compensation; TechnologyTechnology | Source reportedE3 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Audit | Not published | Frank A. D'Amelio, John W. Garratt, Marcy S. Klevorn | Not described in the published record |
| Audit; Nominating, Governance & Sustainability | Not published | Frank A. D'Amelio | Not described in the published record |
| Audit; Technology | Not published | Marcy S. Klevorn | Not described in the published record |
| Clinical Quality | Not published | David T. Feinberg, Jorge S. Mesquita | Not described in the published record |
| Investment | Not published | John W. Garratt, Jorge S. Mesquita, Kurt J. Hilzinger | Not described in the published record |
| Investment; Clinical Quality | Not published | Jorge S. Mesquita | Not described in the published record |
| Nominating, Governance & Sustainability | Not published | David T. Feinberg, Frank A. D'Amelio, Karen W. Katz | Not described in the published record |
| Nominating, Governance & Sustainability; Clinical Quality | Not published | David T. Feinberg | Not described in the published record |
| Organization & Compensation | Not published | Gordon Smith, Karen W. Katz, Wayne A.I. Frederick M.D | Not described in the published record |
| Organization & Compensation; Nominating, Governance & Sustainability | Not published | Karen W. Katz | Not described in the published record |
| Organization & Compensation; Technology | Not published | Gordon Smith, Wayne A.I. Frederick M.D | Not described in the published record |
| Technology | Not published | Gordon Smith, Marcy S. Klevorn, Wayne A.I. Frederick M.D | Not described in the published record |
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Financials and market context
Evidence| Index | Security | Status | Effective | Verification | Source |
|---|---|---|---|---|---|
| S&P 500 (S&P Dow Jones Indices) | NYSE: HUM | current | Dec 10, 2012 | inferred | Slickcharts S&P 500 constituent table (public observation, not S&P DJI license) |
Governance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Aaron C. MartinPresident, Medicare Advantagecompany:c1aa5809-cafb-4c18-8613-236fb1c5da0e:leadership_role:19
- Celeste M. MelletChief Financial Officercompany:c1aa5809-cafb-4c18-8613-236fb1c5da0e:leadership_role:20
- David E. DintenfassPresident, Enterprise Growthcompany:c1aa5809-cafb-4c18-8613-236fb1c5da0e:leadership_role:21
- George Renaudin IIPresident, Insurancecompany:c1aa5809-cafb-4c18-8613-236fb1c5da0e:leadership_role:22
- James A. RechtinPresident and Chief Executive Officer, Directorcompany:c1aa5809-cafb-4c18-8613-236fb1c5da0e:leadership_role:23, company:c1aa5809-cafb-4c18-8613-236fb1c5da0e:leadership_role:13
- Japan A. MehtaChief Information Officercompany:c1aa5809-cafb-4c18-8613-236fb1c5da0e:leadership_role:24
- John-Paul W. FelterSenior Vice President, Chief Accounting Officer and Controllercompany:c1aa5809-cafb-4c18-8613-236fb1c5da0e:leadership_role:25
- Joseph C. VenturaChief Legal Officercompany:c1aa5809-cafb-4c18-8613-236fb1c5da0e:leadership_role:26
- Michelle A. O'HaraChief Human Resources Officercompany:c1aa5809-cafb-4c18-8613-236fb1c5da0e:leadership_role:27
- Sandra Horning, M.D.President, CenterWellcompany:c1aa5809-cafb-4c18-8613-236fb1c5da0e:leadership_role:28
- David T. FeinbergIndependent Directorcompany:c1aa5809-cafb-4c18-8613-236fb1c5da0e:leadership_role:10
- Frank A. D'AmelioIndependent Directorcompany:c1aa5809-cafb-4c18-8613-236fb1c5da0e:leadership_role:11
- Gordon SmithIndependent Directorcompany:c1aa5809-cafb-4c18-8613-236fb1c5da0e:leadership_role:12
- Jorge S. MesquitaIndependent Directorcompany:c1aa5809-cafb-4c18-8613-236fb1c5da0e:leadership_role:14
- Karen W. KatzIndependent Directorcompany:c1aa5809-cafb-4c18-8613-236fb1c5da0e:leadership_role:15
- Kurt J. HilzingerChaircompany:c1aa5809-cafb-4c18-8613-236fb1c5da0e:leadership_role:9
- Marcy S. KlevornIndependent Directorcompany:c1aa5809-cafb-4c18-8613-236fb1c5da0e:leadership_role:16
- Raquel C. Bono M.DIndependent Directorcompany:c1aa5809-cafb-4c18-8613-236fb1c5da0e:leadership_role:17
- John W. GarrattDirector (committee appointment)company:c1aa5809-cafb-4c18-8613-236fb1c5da0e:committee_record:29
- Wayne A.I. Frederick M.DIndependent Directorcompany:c1aa5809-cafb-4c18-8613-236fb1c5da0e:leadership_role:18
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 15 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 15, 2026. Cited by 6 Claims.
- E2HUMANA INC Form 10-K (filed 2026-02-19). SEC filing. Retrieved Aug 29, 2026. Cited by 2 Claims.
- E3sec proxy. Published Mar 6, 2026. Retrieved Mar 23, 2026. Cited by 10 Claims.
- E4HUM executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E5HUM executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E6HUM executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E7HUM executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E8HUM executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E9HUM executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E10HUM executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E11HUM executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E12HUM executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E13HUM executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E14board_seats. sp500-board-director-completeness-remediation-2026-05-15. Cited by 23 Claims.
- E15Slickcharts S&P 500 constituent table (public observation, not S&P DJI license). index provider. Retrieved Sep 2, 2026. Cited by 1 Claim.
What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 15, 2026- Gordon Smith seat on Humana, effective 2024-01-01.
- James A. Rechtin seat on Humana, effective 2024-01-01.
- Organization & Compensation; Technology committee of Humana, effective 2024-01-01.
- Gordon Smith member of Organization & Compensation; Technology, effective 2024-01-01.
- David T. Feinberg seat on Humana, effective 2022-01-01.
- Nominating, Governance & Sustainability; Clinical Quality committee of Humana, effective 2022-01-01.
- David T. Feinberg member of Nominating, Governance & Sustainability; Clinical Quality, effective 2022-01-01.
- Jorge S. Mesquita seat on Humana, effective 2021-01-01.
- Marcy S. Klevorn seat on Humana, effective 2021-01-01.
- Audit; Technology committee of Humana, effective 2021-01-01.
- Marcy S. Klevorn member of Audit; Technology, effective 2021-01-01.
- Investment; Clinical Quality committee of Humana, effective 2021-01-01.
- Jorge S. Mesquita member of Investment; Clinical Quality, effective 2021-01-01.
- Raquel C. Bono M.D seat on Humana, effective 2020-01-01.
- Karen W. Katz seat on Humana, effective 2019-01-01.
- Organization & Compensation; Nominating, Governance & Sustainability committee of Humana, effective 2019-01-01.
- Karen W. Katz member of Organization & Compensation; Nominating, Governance & Sustainability, effective 2019-01-01.
- Frank A. D'Amelio seat on Humana, effective 2003-01-01.
- Kurt J. Hilzinger seat on Humana, effective 2003-01-01.
- Kurt J. Hilzinger chairs board Humana, effective 2003-01-01.
- Audit; Nominating, Governance & Sustainability committee of Humana, effective 2003-01-01.
- Frank A. D'Amelio member of Audit; Nominating, Governance & Sustainability, effective 2003-01-01.

